Prospects of neutralizing nanobodies against SARS-CoV-2
F Chen, Z Liu, F Jiang - Frontiers in immunology, 2021 - frontiersin.org
Since December 2019, the SARS-CoV-2 has erupted on a large scale worldwide and
spread rapidly. Passive immunization of antibody-related molecules provides opportunities …
spread rapidly. Passive immunization of antibody-related molecules provides opportunities …
Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2
W Wang, Y Hu, B Li, H Wang, J Shen - Biochemical Pharmacology, 2023 - Elsevier
Global health and economy are deeply influenced by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and its newly emerging variants. Nanobodies with nanometer …
coronavirus 2 (SARS-CoV-2) and its newly emerging variants. Nanobodies with nanometer …
Emerging landscape of nanobodies and their neutralizing applications against SARS-CoV-2 virus
X Feng, H Wang - ACS Pharmacology & Translational Science, 2023 - ACS Publications
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the
coronavirus disease 2019 (COVID-19) has significantly altered people's way of life. Despite …
coronavirus disease 2019 (COVID-19) has significantly altered people's way of life. Despite …
The potential of nanobodies for COVID-19 diagnostics and therapeutics
DB Naidoo, AA Chuturgoon - Molecular Diagnosis & Therapy, 2023 - Springer
The infectious severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent for coronavirus disease 2019 (COVID-19). Globally, there have been …
causative agent for coronavirus disease 2019 (COVID-19). Globally, there have been …
Nanobodies: prospects of expanding the gamut of neutralizing antibodies against the novel coronavirus, SARS-CoV-2
R Konwarh - Frontiers in immunology, 2020 - frontiersin.org
With more than 6.9 M confirmed cases and∼ 400K deaths as on June 8, 2020 (1), COVID-
19, ushered in by the SARS-CoV-2 has projected itself as a microscopic-holocaust, much …
19, ushered in by the SARS-CoV-2 has projected itself as a microscopic-holocaust, much …
Advances of nanomaterials‐based strategies for fighting against COVID‐19
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has infected over 100
million people globally due to its high infectivity. After decades of efforts on the studies of …
million people globally due to its high infectivity. After decades of efforts on the studies of …
Nanoparticle-based strategies to combat COVID-19
Coronavirus disease 2019 (COVID-19) is the worst pandemic disease of the current
millennium. This disease is caused by the highly contagious severe acute respiratory …
millennium. This disease is caused by the highly contagious severe acute respiratory …
Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models
Nanobodies offer several potential advantages over mAbs for the control of SARS-CoV-2.
Their ability to access cryptic epitopes conserved across SARS-CoV-2 variants of concern …
Their ability to access cryptic epitopes conserved across SARS-CoV-2 variants of concern …
Potential nanoparticle applications for prevention, diagnosis, and treatment of COVID‐19
Abstract The coronavirus disease 2019 (COVID‐19) pandemic caused by the novel severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) poses an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) poses an unprecedented …
Advances in nanomaterial-based platforms to combat COVID-19: Diagnostics, preventions, therapeutics, and vaccine developments
The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …